Health ❯ Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Weight Loss Drugs

Viking’s Oral Obesity Pill Shows Strong Weight Loss but High Dropouts, Triggering Stock Rout

Heavy discontinuation and gastrointestinal side effects raised doubts about its ability to challenge larger rivals in the pill race.

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop

Weight-Loss Drugs Reshape Health and Consumer Markets